FIELD: chemistry; pharmaceutics.
SUBSTANCE: group of inventions relates to pharmaceutical chemistry and includes derivatives of condensed heterocyclyl-carbohydrazonoyl dicyanides of formula 1, pharmaceutically acceptable salts thereof, method of producing said compounds and pharmaceutical compositions based on said compounds. In formula 1, X1 - X3 each independently represents N or C(H); Y1 and Y2 each independently represents N(R4), C(H), O or S, and at least one of Y1 and Y2 is N (R4); n is 0 or 1; is or to form an aromatic or non-aromatic fused heterocyclic ring; R1 is hydrogen, C1-6 alkyl or C1-6 alkylcarbonyl; R2 and R3 each independently represents hydrogen, C1-6alkyl, halogen or C1-6 alkoxy; and R4 is hydrogen, C1-6alkyl, C1-6 haloalkyl, C3-6 cycloalkyl-C0-6 alkyl or C6-10 aryl.
EFFECT: compounds of formula 1, which inhibit tau protein aggregation.
20 cl, 5 tbl, 65 ex
Title | Year | Author | Number |
---|---|---|---|
HETEROARYL COMPOUNDS, COMPOSITIONS CONTAINING THEM AND METHODS OF TREATING WITH USE OF SUCH COMPOUNDS | 2007 |
|
RU2478635C2 |
NOVEL HETEROCYCLIC COMPOUND, METHOD FOR PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITION CONTAINING SAME | 2018 |
|
RU2733384C1 |
4-(IMIDAZO[1,2-A]PYRIDIN-3-YL)-PYRIMIDINE DERIVATIVES | 2020 |
|
RU2822388C2 |
BENZOXAZEPINE PI3 INHIBITORS AND METHODS OF USE | 2010 |
|
RU2654068C1 |
NOVEL CONDENSED DERIVATIVES OF IMIDAZOLE, INHIBITORS OF DIPEPTIDYL PEPTIDASE IV, PHARMACEUTICAL COMPOSITION, METHOD OF TREATMENT AND USING BASED ON THEREOF | 2003 |
|
RU2297418C9 |
CHEMICAL COMPOUNDS 637: PYRIDOPYRIMIDINEDIONES AS PDE4 INHIBITORS | 2008 |
|
RU2479584C2 |
NOVEL PYRAZOLE DERIVATIVES | 2022 |
|
RU2816835C1 |
BENZOXAZEPINE PI3K INHIBITORS AND METHODS OF USE | 2010 |
|
RU2600927C2 |
HETEROCYCLIC COMPOUND AS PROTEIN KINASE INHIBITOR | 2018 |
|
RU2783723C2 |
N1/N2-LACTAM ACETYL-CoA-CARBOXYLASE INHIBITORS | 2011 |
|
RU2540337C2 |
Authors
Dates
2024-09-03—Published
2021-06-18—Filed